SQUAWK/NEWS
Account
Theme
Account
Menu
Live News REGULATION FLASH M impact

FDA approves AstraZeneca’s Imfinzi plus EV for bladder cancer

AstraZeneca said its Imfinzi plus EV regimen has been approved in the US for bladder cancer.

Story updates

07:12:30 AM UTC
SquawkNews
... AstraZeneca Based on VOLGA Phase III trial data which showed a 49% reduction in risk of recurren

Related stories